Streetbeat News

Price Targets

OPCH

Truist Securities has maintained a Buy rating on Option Care Health but lowered the price target from $41 to $34.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:15 am

BJRI

Wedbush analyst Nick Setyan has reiterated an Outperform rating for BJ's Restaurants (NASDAQ:BJRI) and maintained a price target of $43.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:14 am

NXT

Truist Securities has maintained a Buy rating on NEXTracker and raised its price target from $50 to $54, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:10 am

VIR

Needham analyst Joseph Stringer has reiterated a Buy rating on Vir Biotechnology (NASDAQ:VIR) and maintained a price target of $19.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:09 am

AAPL

Jim Cramer suggests that Apple's stock was overvalued following its Q3 earnings, despite a strong iPhone 16 launch defended by analyst Dan Ives. Apple's Q4 revenue and earnings exceeded expectations, but forecast cuts and aggressive pricing strategies in China have impacted its stock price.

Portfolio Pulse from Ananya Gairola

November 01, 2024 | 10:08 am

CIFR

Needham analyst John Todaro has reiterated a Buy rating on Cipher Mining (NASDAQ:CIFR) and maintained a price target of $7.5.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:08 am

IDA

Mizuho analyst Anthony Crowdell has upgraded Idacorp (NYSE:IDA) from Neutral to Outperform and increased the price target from $102 to $116.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:07 am

ALNY

Needham analyst Joseph Stringer has reiterated a Buy rating on Alnylam Pharmaceuticals (NASDAQ:ALNY) and maintained a price target of $320.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:06 am

BCC

Loop Capital has initiated coverage on Boise Cascade with a Buy rating and set a price target of $155.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:04 am

AMZN

Goldman Sachs analyst Eric Sheridan has maintained a Buy rating on Amazon.com and raised the price target from $230 to $240.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:00 am